However, it is speculated that since metformin downregulates the expression of pro-inflammatory cytokines, such as TNF-α and IL-6, via NF-κB inhibition and contributes to the suppression of aging-related inflammatory pathways (46–48), similar benefits may be seen in LHON. Here, NFKB1 is linked to Leber hereditary optic neuropathy.